Clinical cardiology · 2010
Long-term outcome of 4 Korean families with hypertrophic cardiomyopathy caused by 4 different mutations.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Choi Jin-Oh, Yu Cheol-Woong, Chun Nah Jong, Rang Park Jeong, Lee Bok-Soo, Jeong Choi Yu, Cho Byung-Ryul, Lee Sang-Chol, Woo Park Seung, Kimura Akinori, Euy Park Jeong
Аннотация
BACKGROUND: We sought to describe the long-term outcome of individuals in 4 Korean families with hypertrophic cardiomyopathy (HCM) with known mutations.
HYPOTHESIS: Long-term clinical features of familial HCM might be characterized according to the mutation causing HCM.
METHODS: We performed long-term (mean, 13.1 y) clinical evaluations on 46 subjects from 4 Korean families with different mutations.
RESULTS: Myosin light chain 3 gene (MYL3) mutation was associated with late-onset HCM with relatively poor prognosis; 1 sudden cardiac death and 2 cases of heart failure with atrial fibrillation occurred among 12 subjects with this mutation. Myosin binding protein C gene (MYBPC3) mutation was associated with 2 cases of sudden cardiac death and 3 cases of heart failure among 7 affected members. Cardiac troponin I type 3 gene (TNNI3) mutation was associated with 5 deaths related to atrial fibrillation and stroke among 12 mutation-positive members. Myosin heavy chain 7 gene (MYH7) mutation was associated with 11 deaths in 15 affected members.
CONCLUSIONS: The clinical course was quite different for different HCM mutations. Even within the same family, individuals carrying the same mutation differed in disease expression and prognosis.
HYPOTHESIS: Long-term clinical features of familial HCM might be characterized according to the mutation causing HCM.
METHODS: We performed long-term (mean, 13.1 y) clinical evaluations on 46 subjects from 4 Korean families with different mutations.
RESULTS: Myosin light chain 3 gene (MYL3) mutation was associated with late-onset HCM with relatively poor prognosis; 1 sudden cardiac death and 2 cases of heart failure with atrial fibrillation occurred among 12 subjects with this mutation. Myosin binding protein C gene (MYBPC3) mutation was associated with 2 cases of sudden cardiac death and 3 cases of heart failure among 7 affected members. Cardiac troponin I type 3 gene (TNNI3) mutation was associated with 5 deaths related to atrial fibrillation and stroke among 12 mutation-positive members. Myosin heavy chain 7 gene (MYH7) mutation was associated with 11 deaths in 15 affected members.
CONCLUSIONS: The clinical course was quite different for different HCM mutations. Even within the same family, individuals carrying the same mutation differed in disease expression and prognosis.
Предметные рубрики MeSH
AdultAsian PeopleAtrial FibrillationCardiac MyosinsCardiomyopathy, Hypertrophic, FamilialCarrier ProteinsDeath, Sudden, CardiacDisease ProgressionElectrocardiographyFemaleGenetic Predisposition to DiseaseHeart FailureHumansKoreaMagnetic Resonance ImagingMaleMiddle AgedMutationMyosin Heavy ChainsMyosin Light ChainsPedigreePhenotypeStrokeTime FactorsTroponin IMyosin Binding Protein C